Optimizing the pharmacokinetics of an 211 At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor.
Hiroaki EchigoMasayuki MunekaneTakeshi FuchigamiKohshin WashiyamaKenji MishiroHiroshi WakabayashiKazuhiro TakahashiSeigo KinuyaKazuma OgawaPublished in: European journal of nuclear medicine and molecular imaging (2024)
At]1.